The splice of life: Alternative splicing and neurological disease

Splicing of pre-messenger RNA is regulated differently in the brain compared with other tissues. Recognition of aberrations in splicing events that are associated with neurological disease has contributed to our understanding of disease pathogenesis in some cases. Neuron-specific proteins involved in RNA splicing and metabolism are also affected in several neurological disorders. These findings have begun to bridge what we know about the mechanisms regulating neuron-specific splicing and our understanding of neural function and disease.

[1]  M. Garcia-Blanco,et al.  Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. , 1997, RNA.

[2]  M. Goedert,et al.  Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.

[3]  Robert B Darnell,et al.  Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal Viability , 2000, Neuron.

[4]  R. Darnell,et al.  Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. , 2001, Annual review of neuroscience.

[5]  G. Roeder,et al.  Meiosis-specific RNA splicing in yeast , 1991, Cell.

[6]  R. Macdonald.  Ethanol, gamma-aminobutyrate type A receptors, and protein kinase C phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Singer,et al.  Characterization of a beta-actin mRNA zipcode-binding protein , 1997, Molecular and cellular biology.

[8]  M. Swanson,et al.  Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. , 1996, Nucleic acids research.

[9]  Bin Zhang,et al.  Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.

[10]  R. Huganir,et al.  Regulated subcellular distribution of the NR1 subunit of the NMDA receptor. , 1995, Science.

[11]  R. Darnell,et al.  The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo , 1997, Molecular and cellular biology.

[12]  J. Henson,et al.  HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethal , 1991, Cell.

[13]  O. Mühlemann,et al.  Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins , 1998, Nature.

[14]  C. Lorson,et al.  An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. , 2000, Human molecular genetics.

[15]  K. White,et al.  The Neuron-Enriched Splicing Pattern ofDrosophila erect wing Is Dependent on the Presence of ELAV Protein , 2000, Molecular and Cellular Biology.

[16]  S. Liebhaber,et al.  Identification of two KH domain proteins in the alpha‐globin mRNP stability complex. , 1995, The EMBO journal.

[17]  M. Goedert,et al.  Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[18]  J. Rothstein,et al.  Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. , 1992, The New England journal of medicine.

[19]  Michael Ruogu Zhang,et al.  A sequence compilation and comparison of exons that are alternatively spliced in neurons. , 1994, Nucleic acids research.

[20]  J. Pin,et al.  Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.

[21]  Douglas L. Black,et al.  hnRNP H Is a Component of a Splicing Enhancer Complex That Activates a c-src Alternative Exon in Neuronal Cells , 1999, Molecular and Cellular Biology.

[22]  T. Cooper,et al.  Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.

[23]  A. Vezzani,et al.  Alternative Splicing at the C‐terminal but not at the N‐terminal Domain of the NMDA Receptor NR1 is Altered in the Kindled Hippocampus , 1995, The European journal of neuroscience.

[24]  D. Housman,et al.  Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[26]  M. Hentze,et al.  mRNA Silencing in Erythroid Differentiation: hnRNP K and hnRNP E1 Regulate 15-Lipoxygenase Translation from the 3′ End , 1997, Cell.

[27]  R. Darnell,et al.  Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system , 1993, Neuron.

[28]  T. Yagi,et al.  Genomic organization of the family of CNR cadherin genes in mice and humans. , 2000, Genomics.

[29]  R. Darnell,et al.  A Hierarchy of Hu RNA Binding Proteins in Developing and Adult Neurons , 1997, The Journal of Neuroscience.

[30]  R. Crowther,et al.  Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. , 1989, The EMBO journal.

[31]  L. Honig,et al.  Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls , 2000, Neurology.

[32]  D. Lipscombe,et al.  Identification of Functionally Distinct Isoforms of the N-Type Ca2+ Channel in Rat Sympathetic Ganglia and Brain , 1997, Neuron.

[33]  C. Cordon-Cardo,et al.  Neuronal antinuclear antibody in sensory neuronopathy from lung cancer , 1985, Neurology.

[34]  A. Krämer,et al.  Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA. , 1996, RNA.

[35]  Alison M. Goate,et al.  Aberrant Splicing of tau Pre-mRNA Caused by Intronic Mutations Associated with the Inherited Dementia Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 , 2000, Molecular and Cellular Biology.

[36]  R. Huganir,et al.  Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain , 1993, Nature.

[37]  Edwin Reyniers,et al.  A point mutation in the FMR-1 gene associated with fragile X mental retardation , 1993, Nature Genetics.

[38]  P. Grabowski,et al.  Cell- and stage-specific splicing events resolved in specialized neurons of the rat cerebellum. , 1996, RNA.

[39]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[40]  M. Ashiya,et al.  Essential nucleotides direct neuron-specific splicing of gamma 2 pre-mRNA. , 1996, RNA.

[41]  Georg Grön,et al.  The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals , 1999, Journal of the Neurological Sciences.

[42]  C. Cordon-Cardo,et al.  The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. , 1992, The American journal of pathology.

[43]  P. Ince,et al.  CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[44]  Masahiko Watanabe,et al.  Diversity Revealed by a Novel Family of Cadherins Expressed in Neurons at a Synaptic Complex , 1998, Neuron.

[45]  A. Levey,et al.  Localization of neuronal and glial glutamate transporters , 1994, Neuron.

[46]  D L Black,et al.  Conserved intron elements repress splicing of a neuron-specific c-src exon in vitro , 1995, Molecular and cellular biology.

[47]  G. Schellenberg,et al.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[48]  C. Lorson,et al.  SMN oligomerization defect correlates with spinal muscular atrophy severity , 1998, Nature Genetics.

[49]  A. Grover,et al.  5′ Splice Site Mutations in tau Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10* , 1999, The Journal of Biological Chemistry.

[50]  G. Dreyfuss,et al.  A Novel Function for SMN, the Spinal Muscular Atrophy Disease Gene Product, in Pre-mRNA Splicing , 1998, Cell.

[51]  A. Saiardi,et al.  Dopamine D2 receptors in signal transduction and behavior. , 1997, Critical reviews in neurobiology.

[52]  J. Keene.  Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Grabowski.  Genetic Evidence for a Nova Regulator of Alternative Splicing in the Brain , 2000, Neuron.

[54]  M. Hübener,et al.  Activity‐dependent regulation of alternative splicing patterns in the rat brain , 1999, The European journal of neuroscience.

[55]  J. C. Clemens,et al.  Drosophila Dscam Is an Axon Guidance Receptor Exhibiting Extraordinary Molecular Diversity , 2000, Cell.

[56]  R. Darnell,et al.  Sequence-Specific RNA Binding by a Nova KH Domain Implications for Paraneoplastic Disease and the Fragile X Syndrome , 2000, Cell.

[57]  J. Manley,et al.  Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. , 1997, Genes & development.

[58]  D L Black,et al.  A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. , 1997, Genes & development.

[59]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[60]  D. Matthews,et al.  The splicing factor‐associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation , 1999, The EMBO journal.

[61]  S K Burley,et al.  The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[62]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[63]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[64]  C. Guthrie,et al.  Mechanical Devices of the Spliceosome: Motors, Clocks, Springs, and Things , 1998, Cell.

[65]  K. White,et al.  ELAV, a Drosophila neuron-specific protein, mediates the generation of an alternatively spliced neural protein isoform , 1996, Current Biology.

[66]  J. Dalmau,et al.  Hu antigens: Reactivity with hu antibodies, tumor expression, and major immunogenic sites , 1995, Annals of neurology.

[67]  D. Housman,et al.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues , 1995, The Journal of cell biology.

[68]  P. Grabowski,et al.  Coordinate repression of a trio of neuron-specific splicing events by the splicing regulator PTB. , 1999, RNA.

[69]  Michael G. Rosenfeld,et al.  Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products , 1982, Nature.

[70]  R. Darnell.  Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[71]  G. Dreyfuss,et al.  SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Valcárcel,et al.  Alternative pre-mRNA splicing: the logic of combinatorial control. , 2000, Trends in biochemical sciences.

[73]  T. Maniatis,et al.  A Striking Organization of a Large Family of Human Neural Cadherin-like Cell Adhesion Genes , 1999, Cell.

[74]  T. Maniatis,et al.  Common themes in the function of transcription and splicing enhancers. , 1997, Current opinion in cell biology.

[75]  C. Lorson,et al.  A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[76]  R. Darnell,et al.  The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[77]  R. J. White,et al.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. , 2000, Science.

[78]  M. Ashiya,et al.  A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. , 1997, RNA.

[79]  T. Südhof,et al.  Neurexins: three genes and 1001 products. , 1998, Trends in genetics : TIG.

[80]  R. C. Chan,et al.  The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream , 1997, Molecular and cellular biology.

[81]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[82]  J. A. Steitz,et al.  HuR and mRNA stability , 2001, Cellular and Molecular Life Sciences CMLS.

[83]  D. Rio,et al.  Soma-specific expression and cloning of PSI, a negative regulator of P element pre-mRNA splicing. , 1995, Genes & development.

[84]  H. Okado,et al.  Alternative Splicing of the C-Terminal Domain Regulates Cell Surface Expression of the NMDA Receptor NR1 Subunit , 1999, The Journal of Neuroscience.

[85]  K. Yao,et al.  The elav gene product of Drosophila, required in neurons, has three RNP consensus motifs. , 1988, Science.

[86]  P. Grabowski.  Splicing Regulation in Neurons: Tinkering with Cell-Specific Control , 1998, Cell.

[87]  M. Rosenblum,et al.  Anti‐Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 Patients , 1992, Medicine.

[88]  R. H. Brown,et al.  Superoxide dismutase and familial amyotrophic lateral sclerosis: New insights into mechanisms and treatments , 1996, Annals of neurology.

[89]  G. Dreyfuss,et al.  A novel nuclear structure containing the survival of motor neurons protein. , 1996, The EMBO journal.

[90]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[91]  M. Lathrop,et al.  Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q , 1990, Nature.

[92]  Lin Jin,et al.  Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis , 1998, Neuron.

[93]  T. Bird,et al.  An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) , 1999, Nature Genetics.

[94]  R. Darnell,et al.  A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[95]  M. Leppert,et al.  Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q1 1.2–13.3 , 1990, Nature.

[96]  James O. Deshler,et al.  A highly conserved RNA-binding protein for cytoplasmic mRNA localization in vertebrates , 1998, Current Biology.